Insider transaction reported by director F. W. McNabb III at IBM (IBM). The Form 4 shows a transaction dated 09/30/2025 in which 324 Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan were acquired at an indicated share price of $282.16 and recorded as Common Stock. Following this reported transaction, the reporting person beneficially owned 15,223 shares directly. The filing explains these are Promised Fee Shares arising from deferral of director fees, with distribution deferred until the director's retirement and paid in either common stock or cash.
Andrew N. Liveris, a director of International Business Machines Corp. (IBM), reported a non-derivative acquisition on 09/30/2025 of 346 Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan. The filing shows a per-share reference of $282.16 and indicates 42,628 shares beneficially owned by Mr. Liveris following the reported transaction. The Promised Fee Shares are compensation deferrals that are payable after retirement and the distribution is explicitly deferred until retirement. The Form 4 was signed on 10/01/2025.
Michelle J. Howard, a director of International Business Machines Corp. (IBM), received 292 shares of common stock as Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan. The transaction, recorded 09/30/2025, shows the shares were issued at a per-share value of $282.16 and increased her total beneficial ownership to 15,580 shares. The filing explains these Promised Fee Shares represent deferred director fees that are payable after retirement and remain deferred until retirement under the plan.
Alex Gorsky, an IBM director, reported a non‑derivative acquisition on 09/30/2025 involving 381 Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan. Those shares were recorded at a per‑share value of $282.16. Following the transaction, Gorsky beneficially owns 32,805 shares of IBM common stock on a direct basis. The filing notes the shares are part of a deferred compensation arrangement and that distribution of the Promised Fee Shares is deferred until retirement. This Form 4 reflects a routine fee deferral by a director rather than an open‑market purchase or sale.
Marianne C. Brown, a director of International Business Machines Corp (IBM), reported a non-derivative acquisition related to deferred director fees. The Form 4 shows a transaction dated 09/30/2025 in which 324 Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan were recorded as acquired at a stated fee/share price of $282.16. Those Promised Fee Shares are payable after retirement and are deferred until retirement. Following this reported transaction, Ms. Brown beneficially owns 2,947 shares of IBM common stock in a direct ownership form. The filing was executed on 10/01/2025.
Reporting person Nicolas A. Fehring, Vice President and Controller of International Business Machines Corporation (IBM), filed a Form 4 reporting transactions on September 1-2, 2025. The filing shows vested restricted stock units (RSUs) and related share movements: 2,742 RSUs were released and converted to 2,742 shares on 09/01/2025, a sale of 1,388 shares at $243.59 on 09/01/2025, and a disposition of 400 shares on 09/02/2025.
After these transactions the reporting person beneficially owned 13,735.419 shares. The Form 4 explains the RSU grant history (original grant on 09/01/2021 with vesting tranches) and notes certain RSUs are payable in cash or common stock with future vesting dates.